79
Views
3
CrossRef citations to date
0
Altmetric
Articles

Association between paraoxonase-1 gene Q192R and L55M polymorphisms and risk of gastric cancer: A case-control study from Iran

, , &
Pages 521-532 | Received 18 May 2018, Accepted 19 Jan 2019, Published online: 11 Mar 2019

References

  • Rugge, M.; Fassan, M.; Graham, D. Y. Epidemiology of Gastric Cancer. In Gastric Cancer; Springer: New York, 2015; pp 23–34.
  • Compare, D.; Rocco, A.; Nardone, G. Risk Factors in Gastric Cancer. Eur. Rev. Med. Pharmacol. Sci. 2010, 14, 302–308.
  • Graham, D. Y. Helicobacter pylori Update: Gastric Cancer, reliable Therapy, and Possible Benefits. Gastroenterology. 2015, 148, 719–731.e3. DOI:10.1053/j.gastro.2015.01.040.
  • Kanda, M.; Nomoto, S.; Oya, H.; Takami, H.; Shimizu, D.; Hibino, S.; Hashimoto, R.; Kobayashi, D.; Tanaka, C.; Yamada, S.; et al. The Expression of Melanoma-associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression. Ann. Surg. Oncol. 2016, 23, 214–221. DOI:10.1245/s10434-015-4457-8.
  • Furlong, C. E.; Marsillach, J.; Jarvik, G. P.; Costa, L. G. Paraoxonases-1,-2 and-3: What Are Their Functions? Chem. Biol. Interact. 2016, 259, 51–62. DOI:10.1016/j.cbi.2016.05.036.
  • Devarajan, A.; Shih, D.; Reddy, S. T. Inflammation, Infection, Cancer and All That… The role of Paraoxonases. In Oxidative Stress and Inflammation in Non-communicable Diseases-Molecular Mechanisms and Perspectives in Therapeutics; Springer: New York, 2014; pp 33–41.
  • Teiber, J. F.; Kramer, G. L.; de Lemos, J. A.; Drazner, M. H.; Haley, R. W. Abstract 17217. Circulation. 2015, 132, A17217.
  • Mega, J. L.; Close, S. L.; Wiviott, S. D.; Man, M.; Duvvuru, S.; Walker, J. R.; Sundseth, S. S.; Collet, J.-P.; Delaney, J. T.; Hulot, J.-S.; et al. PON1 Q192R Genetic Variant and Response to Clopidogrel and Prasugrel: Pharmacokinetics, Pharmacodynamics, and a Meta-analysis of Clinical Outcomes. J. Thromb. Thrombolysis 2016, 41, 374–383. DOI:10.1007/s11239-015-1264-9.
  • Hagmann, H.; Kuczkowski, A.; Ruehl, M.; Lamkemeyer, T.; Brodesser, S.; Horke, S.; Dryer, S.; Schermer, B.; Benzing, T.; Brinkkoetter, P. T. Breaking the Chain at the Membrane: Paraoxonase 2 Counteracts Lipid Peroxidation at the Plasma Membrane. FASEB J. 2014, 28, 1769–1779. DOI:10.1096/fj.13-240309.
  • Türkeş, C.; Söyüt, H.; Beydemir, Ş. Effect of Calcium Channel Blockers on Paraoxonase-1 (PON1) Activity and Oxidative Stress. Pharmacolo. Rep. 2014, 66, 74–80. DOI:10.1016/j.pharep.2013.08.007.
  • Gawade, G.; Padwal, M. K.; Melinkeri, R. Oxidative Stress and Paraoxonase (PON-1) Status in Diabetic Nephropathy. Int. J. Health Sci. Res. 2015, 5, 177–184.
  • Demir, Y.; Beydemir, Ş. Purification, Refolding, and Characterization of Recombinant Human Paraoxonase-1. Turk. J. Chem. 2015, 39, (4), 764–776. DOI:10.3906/kim-1501-51.
  • Mackness, M.; Mackness, B. Human Paraoxonase-1 (PON1): Gene Structure and Expression, promiscuous Activities and Multiple Physiological Roles. Gene. 2015, 567, 12–21. DOI:10.1016/j.gene.2015.04.088.
  • Sunay, S. Z.; Kayaaltı, Z.; Bayrak, T.; Söylemezoğlu, T. Effect of Paraoxonase 1 192 Q/R Polymorphism on Paraoxonase and Acetylcholinesterase Enzyme Activities in a Turkish Population Exposed to Organophosphate. Toxicol. Ind. Health 2015, 31, 1061–1068. DOI:10.1177/0748233713487246.
  • Sosa, V.; Moliné, T.; Somoza, R.; Paciucci, R.; Kondoh, H.; LLeonart, M. E. Oxidative Stress and Cancer: An Overview. Ageing Res. Rev. 2013, 12, 376–390.
  • Sies, H.; Berndt, C.; Jones, D. P. Oxidative Stress. Annu. Rev. Biochem. 2017, 86, 715–748.
  • Li, H.; Horke, S.; Förstermann, U. Vascular Oxidative Stress, Nitric Oxide and Atherosclerosis. Atherosclerosis 2014, 237, 208–219.
  • Nathan, C.; Cunningham-Bussel, A. Beyond Oxidative Stress: An Immunologist’s Guide to Reactive Oxygen Species. Nat. Rev. Immunol. 2013, 13, 349–361. DOI:10.1038/nri3423.
  • Lushchak, V. I. Free Radicals, Reactive Oxygen Species, Oxidative Stress and Its Classification. Chem. Biol. Interact. 2014, 224, 164–175. DOI:10.1016/j.cbi.2014.10.016.
  • Zargari, M.; Sharafeddin, F.; Mahrooz, A.; Alizadeh, A.; Masoumi, P. The Common Variant Q192R at the Paraoxonase 1 (PON1) Gene and Its Activity Are Responsible for a Portion of the Altered Antioxidant Status in Type 2 Diabetes. Exp. Biol. Med. (Maywood) 2016, 241, 1489–1496. DOI:10.1177/1535370216641786.
  • Deakin, S. P.; James, R. W. Genetic and Environmental Factors Modulating Serum Concentrations and Activities of the Antioxidant Enzyme Paraoxonase-1. Clin. Sci. 2004, 107, 435–447. DOI:10.1042/CS20040187.
  • Sentí, M.; Tomás, M.; Fitó, M.; Weinbrenner, T.; Covas, M.-I.; Sala, J.; Masiá, R.; Marrugat, J. Antioxidant Paraoxonase 1 Activity in the Metabolic Syndrome. J. Clin. Endocrinol. Metab. 2003, 88, 5422–5426. DOI:10.1210/jc.2003-030648.
  • Elkiran, E. T.; Mar, N.; Aygen, B.; Gursu, F.; Karaoglu, A.; Koca, S. Serum Paraoxonase and Arylesterase Activities in Patients with Lung Cancer in a Turkish Population. BMC Cancer. 2007, 7, 48.
  • Akcay, M.; Polat, M.; Yilmaz, I.; Akcay, G. Serum Paraoxonase Levels in Pancreatic Cancer. Hepatogastroenterology. 2003, 50, ccxxv–ccxxvii.
  • Kerridge, I.; Lincz, L.; Scorgie, F.; Hickey, D.; Granter, N.; Spencer, A. Association between Xenobiotic Gene Polymorphisms and Non-Hodgkin’s Lymphoma Risk. Br. J. Haematol. 2002, 118, 477–481.
  • Stevens, V. L.; Rodriguez, C.; Pavluck, A. L.; Thun, M. J.; Calle, E. E. Association of Polymorphisms in the Paraoxonase 1 Gene with Breast Cancer Incidence in the CPS-II Nutrition Cohort. Cancer Epidemiol. Biomarkers Prev. 2006, 15, 1226–1228. DOI:10.1158/1055-9965.EPI-05-0930.
  • Antognelli, C.; Mearini, L.; Talesa, V. N.; Giannantoni, A.; Mearini, E. Association of CYP17, GSTP1, and PON1 Polymorphisms with the Risk of Prostate Cancer. Prostate. 2005, 63, 240–251.
  • Eom, S. Y.; Yim, D. H.; Lee, C. H.; Choe, K. H.; An, J. Y.; Lee, K. Y.; Kim, Y. D.; Kim, H. Interactions between Paraoxonase 1 Genetic Polymorphisms and Smoking and Their Effects on Oxidative Stress and Lung Cancer Risk in a Korean Population. PLoS One. 2015, 10, e0119100. DOI:10.1371/journal.pone.0119100.
  • Zhang, M.; Xiong, H.; Fang, L.; Lu, W.; Wu, X.; Huang, Z. S.; Wang, Y. Q.; Cai, Z. M.; Wu, S. Paraoxonase 1 (PON1) Q192R Gene Polymorphism and Cancer Risk: A Meta-Analysis Based on 30 Publications. Asian Pac. J. Cancer Prev. 2015, 16, 4457–4463.
  • Geng, R.; Chen, Z.; Zhao, X.; Qiu, L.; Liu, X.; Liu, R.; Guo, W.; He, G.; Li, J.; Zhu, X. Oxidative Stress-related Genetic Polymorphisms Are Associated with the Prognosis of Metastatic Gastric Cancer Patients Treated with Epirubicin, oxaliplatin and 5-fluorouracil Combination Chemotherapy. PLoS One. 2014, 9, e116027. DOI:10.1371/journal.pone.0116027.
  • Atay, A. E.; Kaplan, M. A.; Evliyaoglu, O.; Ekin, N.; Isikdogan, A. The Predictive Role of Paraoxonase 1 (PON1) activity on Survival in Patients with Metastatic and Nonmetastatic Gastric Cancer. Clin. Ter. 2014, 165, e1–e5.
  • Rao, K. S. Free Radical Induced Oxidative Damage to DNA: relation to Brain Aging and Neurological Disorders. Indian J. Biochem. Biophys. 2009, 46, 9–15.
  • Shih, D. M.; Gu, L.; Xia, Y. R.; Navab, M.; Li, W. F.; Hama, S.; Castellani, L. W.; Furlong, C. E.; Costa, L. G.; Fogelman, A. M.; Lusis, A. J. Mice Lacking Serum Paraoxonase Are Susceptible to Organophosphate Toxicity and Atherosclerosis. Nature. 1998, 394, 284–287. DOI:10.1038/28406.
  • Gupta, N.; Gill, K.; Singh, S. Paraoxonases: Structure, gene Polymorphism & Role in Coronary Artery Disease. Indian J. Med. Res. 2009, 130, 361–368.
  • Vecka, M.; Jachymova, M.; Vavrova, L.; Kodydkova, J.; Macasek, J.; Urbanek, M.; Krechler, T.; Slaby, A.; Duskova, J.; Muravska, A.; Zak, A. Paraoxonase-1 (PON1) Status in Pancreatic Cancer: Relation to Clinical Parameters. Folia Biol. (Praha) 2012, 58, 231–237.
  • Krzystek-Korpacka, M.; Boehm, D.; Matusiewicz, M.; Diakowska, D.; Grabowski, K.; Gamian, A. Paraoxonase 1 (PON1) status in Gastroesophageal Malignancies and Associated Paraneoplastic Syndromes - Connection with Inflammation. Clin. Biochem. 2008, 41, 804–811. DOI:10.1016/j.clinbiochem.2008.03.012.
  • Kafadar, A. M.; Ergen, A.; Zeybek, U.; Agachan, B.; Kuday, C.; Isbir, T. Paraoxonase 192 Gene Polymorphism and Serum Paraoxonase Activity in High Grade Gliomas and Meningiomas. Cell Biochem. Funct. 2006, 24, 455–460. DOI:10.1002/cbf.1284.
  • Oztürk, O.; Kağnici, O. F.; Oztürk, T.; Durak, H.; Tüzüner, B. M.; Kisakesen, H. I.; Cakalir, C.; Isbir, T. 192R Allele of Paraoxanase 1 (PON1) gene as a New Marker for Susceptibility to Bladder Cancer. Anticancer Res. 2009, 29, 4041–4046.
  • Lurie, G.; Wilkens, L. R.; Thompson, P. J.; McDuffie, K. E.; Carney, M. E.; Terada, K. Y.; Goodman, M. T. Genetic Polymorphisms in the Paraoxonase 1 Gene and Risk of Ovarian Epithelial Carcinoma. Cancer Epidemiol. Biomarkers Prev. 2008, 17, 2070–2077. DOI:10.1158/1055-9965.EPI-08-0145.
  • Ergen, A.; Kilicoglu, O.; Ozger, H.; Agachan, B.; Isbir, T. Paraoxonase 1 192 and 55 Polymorphisms in Osteosarcoma. Mol. Biol. Rep. 2011, 38, 4181–4184.
  • Stevens, V. L.; Rodriguez, C.; Talbot, J. T.; Pavluck, A. L.; Thun, M. J.; Calle, E. E. Paraoxonase 1 (PON1) polymorphisms and Prostate Cancer in the CPS-II Nutrition Cohort. Prostate. 2008, 68, 1336–1340.
  • Uyar, O. A.; Kara, M.; Erol, D.; Ardicoglu, A.; Yuce, H. Investigating Paraoxonase-1 Gene Q192R and L55M Polymorphism in Patients with Renal Cell Cancer. Genet. Mol. Res. 2011, 10, 133–139.
  • Boland, C. R.; Luciani, M. G.; Gasche, C.; Goel, A. Infection, Inflammation, and Gastrointestinal Cancer. Gut. 2005, 54, 1321–1331.
  • Ma, Y.; Zhang, L.; Rong, S.; Qu, H.; Zhang, Y.; Chang, D.; Pan, H.; Wang, W. Relation Between Gastric Cancer and Protein Oxidation, DNA Damage, and Lipid Peroxidation. Oxid. Med. Cell Longev. 2013, 2013, 1. DOI:10.1155/2013/543760.
  • Muntoni, S.; Atzori, L.; Mereu, R.; Satta, G.; Macis, M. D.; Congia, M.; Tedde, A.; Desogus, A.; Muntoni, S. Serum Lipoproteins and Cancer. Nutr. Metab. Cardiovasc. Dis. 2009, 19, 218–225.
  • Mackness, M.; Arrol, S.; Mackness, B.; Durrington, P. N. Alloenzymes of Paraoxonase and Effectiveness of High-density Lipoproteins in Protecting Low-density Lipoprotein Against Lipid Peroxidation. Lancet. 1997, 349, 851–852. DOI:10.1016/S0140-6736(05)61755-2.
  • Van Der Logt, E. M.; Janssen, C. H.; VAN Hooijdonk, Z.; Roelofs, H. M.; Wobbes, T.; Nagengast, F. M.; Peters, W. H. No Association Between Genetic Polymorphisms in NAD (P) H Oxidase p22phox and Paraoxonase 1 and Colorectal Cancer Risk. Anticancer Res. 2005, 25, 1465–1470.
  • Nielsen, S. S.; McKean-Cowdin, R.; Farin, F. M.; Holly, E. A.; Preston-Martin, S.; Mueller, B. A. Childhood Brain Tumors, Residential Insecticide Exposure, and Pesticide Metabolism Genes. Environ. Health Perspect. 2010, 118, 144–149. DOI:10.1289/ehp.0901226.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.